Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.

Adverse event monitoring poorer in patients on amiodarone vs dofetilide

10 Oct 2018

Monitoring of adverse events is lower in ambulatory patients on amiodarone than in those on dofetilide, a recent study has found. Improving the monitoring of such agents may help reduce the risk of morbidity in this population.

In total, 100 patients (amiodarone: n=50; dofetilide: n=50) were included in the analysis. Average rates of 55 percent and 57 percent were recorded for baseline and follow-up amiodarone monitoring parameters, respectively. The corresponding rates for dofetilide monitoring were 99.6 percent and 85 percent.

After prescribing amiodarone to patients, a statistically significant difference was observed in abnormally elevated thyroid-stimulating hormone levels (8–30 percent; p≤0.005). Furthermore, an increase in QTc interval by >15 percent was seen in 12 percent of patients taking dofetilide.

This study included patients prescribed amiodarone or dofetilide for a 2-year period to assess whether they were being monitored according to package labeling and guideline recommendations for adverse events. Those with ventricular arrhythmias, prescribed >1 antiarrhythmic agent, or received antiarrhythmic monitoring outside the healthcare system were excluded.

Frequency of baseline and follow-up monitoring recommendations for patients receiving amiodarone or dofetilide was the primary outcome, while secondary outcomes were the rates of adverse drug events.

“Published studies state that adherence to regular laboratory assessments for antiarrhythmic drugs is as low as 20 percent,” the authors said. “Monitoring adherence is important as other studies have shown that up to 93 percent of patients on amiodarone experience an adverse drug event leading to a potentially lethal event.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.